Long-term seropositivity, safety, and impact of inactivated and live, attenuated hepatitis a vaccines in China – A cross-sectional study
- 1 December 2020
- Vol. 38 (52) , 8302-8309
Abstract
No abstract availableKeywords
Funding Information
- National Major Science and Technology Projects of China
This publication has 17 references indexed in Scilit:
- Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccineVaccine, 2018
- Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of ArgentinaHuman Vaccines & Immunotherapeutics, 2017
- Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, ChinaEmerging Infectious Diseases, 2017
- Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccineHuman Vaccines & Immunotherapeutics, 2017
- Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV studyClinical Microbiology and Infection, 2016
- Surveillance of adverse events following immunization in China: Past, present, and futureVaccine, 2015
- Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling ApproachValue in Health, 2015
- Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated hepatitis a vaccine in childrenHuman Vaccines & Immunotherapeutics, 2015
- Development, Production, and Postmarketing Surveillance of Hepatitis A Vaccines in ChinaJournal of Epidemiology, 2014
- An Epidemic of Hepatitis A Attributable to the Ingestion of Raw Clams in Shanghai, ChinaThe Journal of Infectious Diseases, 1991